Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants

Frontiers in Immunology(2020)10.3389/fimmu.2020.00591Source: DataRank Database

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (28)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jiajia Zhang ORCID,Caroline C. Garliss,Abena K. Kwaa,Joel N. Blankson ORCID,Kellie N. Smith ORCID

Live enrichment

PubMed:32318072 PMC:PMC7154155

NIAID NIH HHS

Grant: P30 AI094189

NIAID NIH HHS

Grant: R01 AI140789

NIAID NIH HHS

Grant: R01 AI120024

National Institutes of Health

Grant: 1R01AI120024-01

A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirs

National Institutes of Health

Grant: 3P30AI094189-13S3

The Johns Hopkins Center for AIDS Research (JHU CFAR)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Mark Foundation For Cancer Research

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.00591/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.00591/full

repositoryhttps://doaj.org/article/476c362e8df840109d66beb3fe09ce81

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7154155

Europe_PMChttps://europepmc.org/articles/PMC7154155

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

CD8-Positive T-LymphocytesHumansHIV-1HIV InfectionsReceptors, Antigen, T-CellEpitopes, T-LymphocyteImmunologic TechniquesCross Reactions

Keywords

HIVcureElite ControllersClonotypeElite SuppressorsCd8 Lymphocytes+ImmunologyReceptors, Antigen, T-CellEpitopes, T-LymphocyteHIV InfectionsRC581-607CD8-Positive T-LymphocytesCross ReactionsHIV-1Immunologic TechniquesHumansImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good health